1. 1761PRisk of health-related quality of life events and pulmonary toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance. (23rd October 2018) Authors: Thein, K Z; Sultan, A; Zaw, M H; Han, M M; Yu, N H; Igid, H P; Jones, C; D'Cunha, N; Awasthi, S; Hardwicke, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 961PRisk of secondary hematological malignancies and hematological toxicities in recurrent ovarian cancer patients treated with poly adenosine diphosphate ribose polymerase (PARP) inhibitors maintenance. (23rd October 2018) Authors: Thein, K Z; Sultan, A; Zaw, M H; Han, M M; Yendala, R; Zin, M M; Awasthi, S; D'Cunha, N; Hardwicke, F; Jones, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comprehensive evaluation of urbanization development quality in Four East China Provinces. Issue 1 (December 2020) Authors: Yang, J; Han, M M; Yao, H M; Liu, T; Wang, Y H Journal: IOP conference series Issue: Volume 594:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗